Status:

RECRUITING

Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol

Lead Sponsor:

Centre Hospitalier Charles Perrens, Bordeaux

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

6-11 years

Phase:

NA

Brief Summary

This research is a case-control study aiming to characterize motor peculiarities (objective quantitative and qualitative measures) and its psycho-physiological correlates of children with ASD.

Detailed Description

The main objective is to measure jointly and in an automated and standardized manner the performance and motor patterns within the framework of tasks measuring the performance and patterns of general ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria :
  • All participants :
  • Be between 6 and 11 years old
  • Mastery of the French language
  • Be affiliated with a Social Security scheme or benefit from affiliation by a third person
  • Both parents (or the holder of legal authority) have read, understood and signed the study consent
  • Be affiliated with social security
  • Participants with ASD should also verify the following inclusion criteria:
  • Being diagnosed with ASD (DSM-V)
  • Exclusion Criteria :
  • All participants :
  • Refusal to participate in the research on the part of the participant and / or holders of parental authority.
  • Be a person benefiting from enhanced protection, namely : persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment.
  • Have uncorrected visual or hearing problems
  • To have concomitant psychotropic drug treatments not stabilized, initiated in the last 2 months: antipsychotics, mood stabilizers, anti-epileptics, psychostimulants, antidepressants.
  • Have a motor handicap of the upper or lower limbs, fitted or not.
  • Have diagnosed neurological or psychiatric disorders, present a general or metabolic pathology having a known impact on the child's motor skills (eg: Epilepsy, Tics and Gilles de la Tourette Syndrome, Intellectual Deficiency, Neuromuscular Syndrome, Metabolic Neurological Syndrome , neoplasms)
  • Suspicion of low intellectual efficiency if at least one of the two subtests (Similarities or Matrices) of WISC V (retrieved from the medical file if the TSA participant) presents a result (standard score) strictly lower than 7.
  • Participants without ASD :
  • Participant with ADHD (Attention Deficit Disorder with or without Hyperactivity) or CDD (Developmental Coordination Disorder)

Exclusion

    Key Trial Info

    Start Date :

    February 7 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 31 2025

    Estimated Enrollment :

    110 Patients enrolled

    Trial Details

    Trial ID

    NCT05236803

    Start Date

    February 7 2022

    End Date

    March 31 2025

    Last Update

    June 18 2024

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Centre Hospitalier Charles Perrens

    Bordeaux, France, 33076

    2

    Centre Hospitalier La Rochelle Re Aunis

    La Rochelle, France, 17019

    3

    CHU de LIMOGES

    Limoges, France, 87042

    4

    Centre Hospitalier Henri Laborit

    Poitiers, France, 86021